Significant benefit seen in Phase III trial of experimental drug for kidney disease
In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria—albumin in urine, a sign of kidney damage—for 50% of participants. When the experimental drug was paired ...
Dec 15, 2023
0
104